about
Relative abundance of short chain and polyunsaturated fatty acids in propionic acid-induced autistic features in rat pups as potential markers in autismAberrant methylation of tRNAs links cellular stress to neuro-developmental disorders.Modeling the interaction between quinolinate and the receptor for advanced glycation end products (RAGE): relevance for early neuropathological processesKynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2(+/-) mice, using liquid chromatography-tandem mass spectrometry.Profiling olfactory stem cells from living patients identifies miRNAs relevant for autism pathophysiologyAutism spectrum disorder in children born preterm-role of exposure to perinatal inflammationRole of NAD(+), Oxidative Stress, and Tryptophan Metabolism in Autism Spectrum Disorders.The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.What's in the pipeline? Drugs in development for autism spectrum disorder.Bergmann Glia, Long-Term Depression, and Autism Spectrum Disorder.Evaluation of whole blood zinc and copper levels in children with autism spectrum disorder.Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: evidence in support of the excitatory/inhibitory imbalance hypothesis.Quinolinic acid induces cell apoptosis in PC12 cells through HIF-1-dependent RTP801 activation.Human CRMP4 mutation and disrupted Crmp4 expression in mice are associated with ASD characteristics and sexual dimorphism.Decreased plasma agmatine levels in autistic subjects.A functional SNP catalog of overlapping miRNA-binding sites in genes implicated in prion disease and other neurodegenerative disorders.Altered cytokine and BDNF levels in autism spectrum disorder.Aberrant tryptophan metabolism: the unifying biochemical basis for autism spectrum disorders?
P2860
Q34252062-723764E1-62CE-41FF-BE16-C0DCB8AB7F29Q34332444-B6B82FF2-5549-4D61-91C8-00B51C6F4FC5Q35163077-CAD30076-E5B5-4B05-885F-899B83CD680BQ36131465-8652AF5D-4EF3-45CC-AF00-C481B404FB45Q36443544-5529395C-0AA4-4B95-BD29-77AF8794D3FFQ37030110-1A158E62-3E71-4D6C-84F0-B8E3311FAE30Q37059666-9C73DCE6-76DF-4DFC-99C6-89AAC7E44C3AQ37559828-F1251EB5-B206-468F-A712-C0B363B653C0Q38193069-A0665BE1-593B-4334-A126-DDA97D71733CQ38711353-A839B0C0-A706-49D8-A9F2-EE335FD73335Q43838839-D76672D6-635C-4307-9047-0BE3B404A1B7Q45902314-FFFCF8B1-666E-4664-AF56-0F0C806E58B0Q46614462-6F009300-56FF-40BB-948D-67D04389DA3BQ47108269-E66B5C8C-FC0E-4FD6-B8F7-1DC334299EDBQ47663697-0587AF56-AF78-4E69-B8C0-6CA108727DBFQ47990584-F14E7A41-3B6F-4EEE-A8E3-0AD80C104C20Q50301293-028EAEA5-76F5-4517-9DEE-1E2D7E3E37CDQ50307699-9E27B549-E575-4AD7-8215-7A77E6F07917
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Excitotoxicity in the pathogenesis of autism.
@en
type
label
Excitotoxicity in the pathogenesis of autism.
@en
prefLabel
Excitotoxicity in the pathogenesis of autism.
@en
P2093
P2860
P1476
Excitotoxicity in the pathogenesis of autism
@en
P2093
P2860
P2888
P304
P356
10.1007/S12640-012-9354-3
P577
2012-10-13T00:00:00Z
P5875
P6179
1027699573